CD39 is an enzyme which is responsible, together with CD73, for a cascade converting adenosine triphosphate into adenosine diphosphate and cyclic adenosine monophosphate, ultimately leading to the release of an immunosuppressive form of adenosine in the tumor microenvironment. Here, we first review the environmental and genetic factors shaping CD39 expression. Second, we report CD39 functions in the T cell compartment, highlighting its role in regulatory T cells, conventional CD4+ T cells and CD8+ T cells. Finally, we compile a list of studies, from preclinical models to clinical trials, which have made essential contributions to the discovery of novel combinatorial approaches in the treatment of cancer
CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydr...
The study of T regulatory cells (T reg cells) has been limited by the lack of specific surface marke...
Abstract Background Cancer cells are known to develop mechanisms to circumvent effective anti-tumor ...
International audienceThe ectonucleotidases CD39 and CD73 hydrolyze extracellular adenosine triphosp...
CD39 is an ectoenzyme, present on different immune cell subsets, which mediates immunosuppressive fu...
CD39 is an ectoenzyme, present on different immune cell subsets, which mediates immunosuppressive fu...
CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydr...
CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydr...
The ectonucleotidases CD39 and CD73 hydrolyze extracellular adenosine triphosphate (ATP) and adenosi...
In this study, we investigated the role of CD39 on tumor-infiltrating CD8+ T lymphocytes (CD8+ TILs)...
In our study, we investigated the role of CD39 on tumor-infiltrating CD8+ T lymphocytes (CD8+ TILs) ...
The ATP–adenosine pathway functions as a key modulator of innate and adaptive immunity within the tu...
Synthesis of extracellular adenosine by the ectonucleotidases CD39 and CD73 represents an important ...
The ability of CD8+ T lymphocytes to eliminate tumors is limited by their ability to engender an imm...
The ability of CD8+ T lymphocytes to eliminate tumors is limited by their ability to engender an imm...
CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydr...
The study of T regulatory cells (T reg cells) has been limited by the lack of specific surface marke...
Abstract Background Cancer cells are known to develop mechanisms to circumvent effective anti-tumor ...
International audienceThe ectonucleotidases CD39 and CD73 hydrolyze extracellular adenosine triphosp...
CD39 is an ectoenzyme, present on different immune cell subsets, which mediates immunosuppressive fu...
CD39 is an ectoenzyme, present on different immune cell subsets, which mediates immunosuppressive fu...
CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydr...
CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydr...
The ectonucleotidases CD39 and CD73 hydrolyze extracellular adenosine triphosphate (ATP) and adenosi...
In this study, we investigated the role of CD39 on tumor-infiltrating CD8+ T lymphocytes (CD8+ TILs)...
In our study, we investigated the role of CD39 on tumor-infiltrating CD8+ T lymphocytes (CD8+ TILs) ...
The ATP–adenosine pathway functions as a key modulator of innate and adaptive immunity within the tu...
Synthesis of extracellular adenosine by the ectonucleotidases CD39 and CD73 represents an important ...
The ability of CD8+ T lymphocytes to eliminate tumors is limited by their ability to engender an imm...
The ability of CD8+ T lymphocytes to eliminate tumors is limited by their ability to engender an imm...
CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydr...
The study of T regulatory cells (T reg cells) has been limited by the lack of specific surface marke...
Abstract Background Cancer cells are known to develop mechanisms to circumvent effective anti-tumor ...